Drug development platform automating pharmacovigilance, regulatory, and clinical workflows
ArisGlobal operates LifeSphere, a SaaS platform for the drug development lifecycle spanning pharmacovigilance, regulatory submissions, and clinical data management. The stack is Java/Spring Boot on AWS with Salesforce integration—a mature, enterprise-grade foundation. Active projects center on global scaling (coverage models, 24/7 support) and cost reduction (support efficiency, architecture redesign), while hiring spans finance, support, and engineering across North America and Europe, suggesting simultaneous investment in customer operations and product infrastructure.
ArisGlobal provides end-to-end software for life sciences companies managing drug development from preclinical through regulatory approval. The platform, LifeSphere, integrates pharmacovigilance (safety signal detection, adverse event reporting), regulatory affairs (submission tracking, eCTD publishing, IDMP compliance), and clinical data management (EDC, eCOA, RTSM). Deployed as multi-tenant SaaS, it serves mid-market and enterprise pharma and biotech. The company operates regional offices in Europe, India, Japan, and China alongside its Waltham headquarters, reflecting a global customer base and distributed operations.
Java, Spring Boot, Node.js, AWS (including Lambda, SQS, ElastiCache, API Gateway), Salesforce, and front-end TypeScript/JavaScript. Testing via JUnit, Mockito, Selenium, and Cucumber.
Headquartered in Waltham, Massachusetts. Currently hiring in the United States, Croatia, Ireland, and Slovenia, with regional offices also in Europe, India, Japan, and China.
Platform development on LifeSphere, global coverage expansion, cloud SaaS infrastructure scaling, support organization growth (24/7 coverage), cost-to-serve reduction, and customer onboarding optimization via continuous process improvement.
Other companies in the same industry, closest in size